Release Date: June 30, 2022
Expiration Date: June 30, 2023
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in advanced prostate cancer. In this educational program, these experts review the selection and sequencing of drugs to match the patient profile, use case scenarios to debate optimal therapeutic sequencing, and analyze efficacy and safety data of emerging agents for metastatic castration-resistant prostate cancer (CRPC).
This educational activity is an archive of the live virtual presentation held on June 4, 2022.
Target Audience
This educational activity is directed toward physicians involved in the treatment of prostate cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Explain clinical trial data and evidence-based recommendations for the management of nonmetastatic and metastatic forms of CRPC
- Determine strategies for to optimize sequencing of current therapies in the care of patients with CRPC
- Assess recent trial evidence from studies that evaluated novel approaches for CRPC in the context of their impact on evolving paradigms in the field
- Apply proactive strategies to monitor for and manage treatment-associated toxicities in CRPC care settings
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
